The influence of ovine MHC class II DRB1 alleles on immune response in bovine leukemia virus infection

Microbiology and Immunology

Volumn 47, Issue 3, 2003, Pages 223-232

  Konnai, Satoru ^a,b   Takeshima, Shin nosuke ^a   Tajima, Shigeru ^a   Yin, Shan Ai ^c   Okada, Kosuke ^c   Onuma, Misao ^b   Aida, Yoko ^a  

^a RIKEN   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c IWATE UNIVERSITY   (Japan)

Author keywords

BLV; Cytokine profile; Neutralizing antibody; Ovine MHC

Indexed keywords

ARGININE; CD4 ANTIGEN; CD5 ANTIGEN; CD8 ANTIGEN; EPITOPE; GAMMA INTERFERON; GENE PRODUCT; GLYCOPROTEIN GP 51; HLA DR ANTIGEN; INTERLEUKIN 2; LEUKOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; SERINE; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ALLELISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCING CELL; ARTICLE; B LYMPHOCYTE; BOVINE LEUKEMIA VIRUS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA SEQUENCE; EXON; FEMALE; GENOTYPE; HELPER CELL; IMMUNE RESPONSE; INFECTION RESISTANCE; INFECTION SENSITIVITY; LYMPHOMA; MALE; MONONUCLEAR CELL; NONHUMAN; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SHEEP; T LYMPHOCYTE; VIRION; VIRUS INFECTION;

ANIMALIA; BOVINAE; BOVINE LEUKEMIA VIRUS; OVIS; OVIS ARIES; RNA VIRUSES;

EID: 0037239641     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2003.tb03391.x     Document Type: Article

References (48)

1. Aida, Y. 2001. Influence of host genetic differences on leukemogenesis induced bovine leukemia virus. AIDS Res. Hum. Retroviruses 17: S12.
2. Aida, Y., Miyasaka, M., Okada, K., Onuma, M., Kogure, S., Suzuki, M., Minoprio, P., Levy, D., and Ikawa, Y. 1989. Further phenotypic characterization of target cells for bovine leukemia virus experimental infection in sheep. Am. J. Vet. Res. 50: 1946-1951.
3. Aida, Y., Okada, K., and Amanuma, H. 1993. Phenotype and ontogeny of cells carrying a tumor-associated antigen that is expressed on bovine leukemia virus-induced lymphosarcoma. Cancer Res. 53: 429-437.
4. Aida, Y., Okada, K., Ohtsuka, M., and Amanuma, H. 1992. Tumor-associated M(r) 34,000 and M(r) 32,000 membrane glycoproteins that are serine phosphorylated specifically in bovine leukemia virus-induced lymphosarcoma cells. Cancer Res. 52: 6463-6470.
5. Altaner, C., Ban, J., Altanerova, V., and Janik, V. 1991. Protective vaccination against bovine leukaemia virus infection by means of cell-derived vaccine. Vaccine 9: 889-895.
6. Burny, A., Cleuter, Y., Kettmann, R., Mammerickx, M., Marbaix, G., Portetelle, D., van den Broeke, A., Willems, L., and Thomas, R. 1988. Bovine leukaemia: facts and hypotheses derived from the study of an infectious cancer. Vet. Microbiol. 17: 197-218.
7. Callebaut, I., Voneche, V., Mager, A., Fumiere, O., Krchnak, V., Merza, M., Zavada, J., Mammerickx, M., Burny, A., and Portetelle, D. 1993. Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51. J. Virol. 67: 5321-5327.
8. nd ed, Vol. 2, Lippincott-Raven, Philadelphia.
9. + lymphocytes by reverse transcriptase polymerase chain reaction. Vet. Immunol. Immunopathol. 49: 39-50.
10. Djilali, S., Parodi, A.-L., Levy, D., and Cockerell, G.L. 1987. Development of leukemia and lymphosarcoma induced by bovine leukemia virus in sheep: a hematopathological study. Leukemia (Baltimore) 1: 777-781.
11. Fu, X.T., Bono, C.P., Woulfe, S.L., Swearingen, C., Summers, N.L., Sinigaglia, F., Sette, A., Schwartz, B.D., and Karr, R.W. 1995. Pocket 4 of the HLA-DR (alpha, beta 1*0401) molecule is a major determinant of T cells recognition of peptide. J. Exp. Med. 181: 915-926.
12. Garcia-Briones, M.M., Russell, G.C., Oliver, R.A., Tami, C., Taboga, O., Carrillo, E., Palma, E.L., Sobrino, F., and Glass, E.J. 2000. Association of bovine DRB3 alleles with immune response to FMDV peptides and protection against viral challenge. Vaccine 19: 1167-1171.
13. Gatei, M.H., Good, M.F., Daniel, R.C., and Lavin, M.F. 1993. T-cell responses to highly conserved CD4 and CD8 epitopes on the outer membrane protein of bovine leukemia virus: relevance to vaccine development. J. Virol. 67: 1796-1802.
14. Gatei, M.H., Naif, H.M., Kumar, S., Boyle, D.B., Daniel, R.C., Good, M.F., and Lavin, M.E 1993. Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70. J. Virol. 67: 1803-1810.
15. Haghparast, A., Wauben, M.H., Grosfeld-Stulemeyer, M.C., van Kooten, P., and Hensen, E.J. 2000. Selection of T-cell epitopes from foot-and-mouth disease virus reflects the binding affinity to different cattle MHC class II molecules. Immunogenetics 51: 733-742.
16. Hislop, A.D., Good, M.F., Mateo, L., Gardner, J., Gatei, M.H., Daniel, R.C., Meyers, B.V., Lavin, M.E, and Suhrbier, A. 1998. Vaccine-induced cytotoxic T lymphocytes protect against retroviral challenge. Nat. Med. 4: 1193-1196.
17. Kabeya, H., Ohashi, K., Ohishi, K., Sugimoto, C., Amanuma, H., and Onuma, M. 1996. An effective peptide vaccine to eliminate bovine leukaemia virus (BLV) infected cells in carrier sheep. Vaccine 14: 1118-1122.
18. Kabeya, H., Ohashi, K., Oyunbileg, N., Nagaoka, Y., Aida, Y., Sugimoto, C., Yokomizo, Y., and Onuma, M. 1999. Upregulation of tumor necrosis factor alpha mRNA is associated with bovine-leukemia virus (BLV) elimination in the early phase of infection. Vet. Immunol. Immunopathol. 68: 255-265.
19. Kabeya, H., Ohashi, K., Sugimoto, C., and Onuma, M. 1999. Characterization of immune responses caused by bovine leukemia virus envelope peptides in sheep. J. Vet. Med. Sci. 61: 475-480.
20. Keefe, R.G., Choi, Y., Ferrick, D.A., and Stott, J.L. 1997. Bovine cytokine expression during different phases of bovine leukemia virus infection. Vet. Immunol. Immunopathol. 56: 39-51.
21. Keefe, R.G., Ferrick, D.A., and Stott, J.L. 1997. Cytokine transcription in lymph nodes of cattle in different stages of bovine leukemia virus infection. Vet. Immunol. Immunopathol. 59: 271-283.
22. Kono, Y., Arai, K., Sentsui, H., Matsukawa, S., and Itohara, S. 1986. Protection against bovine leukemia virus infection in sheep by active and passive immunization. Nippon Juigaku Zasshi 48: 117-125.
23. Lewin, H.A., Russell, G.C., and Glass, E.J. 1999. Comparative organization and function of the major histocompatibility complex of domesticated cattle. Immunol. Rev. 167: 145-158.
24. Mateo, L., Gardner, J., and Suhrbier, A. 2001. Delayed emergence of bovine leukemia virus after vaccination with a protective cytotoxic T cell-based vaccine. AIDS Res. Hum. Retroviruses 17: 1447-1453.
25. Miller, J.M., and Van Der Maaten, M.J. 1978. Evaluation of an inactivated bovine leukemia virus preparation as an immunogen in cattle. Ann. Rech. Vet. 9: 871-877.
26. Mirsky, M.L., Olmstead, C., Da, Y., and Lewin, H.A. 1998. Reduced bovine leukaemia virus proviral load in genetically resistant cattle. Anim. Genet. 29: 245-252.
27. Miyasaka, M., and Trnka, Z. 1985. Sheep as an experimental model for immunology: immunological techniques in vitro and in vivo, Vol. 3, p. 403-422. In Lefkovits, I., and Pernis, B. (eds), Immunological methods, Academic Press, Inc., New York.
28. Murakami, K., Aida, Y., Kageyama, R., Numakunai, S., Ohshima, K., Okada, K., and Ikawa, Y. 1994. Immunopathological study and characterization of the phenotype of transformed cells in sheep with bovine leukemia virus-induced lymphosarcoma. Am. J. Vet. Res. 55: 72-80.
29. + B cells in asymptomatic stage. Virology 202: 458-465.
30. Nagaoka, Y., Kabeya, H., Onuma, M., Kasai, N., Okada, K., and Aida, Y. 1999. Ovine MHC class II DRB 1 alleles associated with resistance or susceptibility to development of bovine leukemia virus-induced ovine lymphoma. Cancer Res. 59: 975-981.
31. Ohishi, K., Suzuki, H., Yamamoto, T., Maruyama, T., Miki, K., Ikawa, Y., Numakunai, S., Okada, K., Ohshima, K., and Sugimoto, M. 1991. Protective immunity against bovine leukaemia virus (BLV) induced in carrier sheep by inoculation with a vaccinia virus-BLV env recombinant: association with cell-mediated immunity. J. Gen. Virol. 72: 1887-1892.
32. Ohishi, K., Suzuki, H., Yasutomi, Y., Onuma, M., Okada, K., Numakunai, S., Ohshima, K., Ikawa, Y., and Sugimoto, M. 1992. Augmentation of bovine leukemia virus (BLV)-specific lymphocyte proliferation responses in ruminants by inoculation with BLV env-recombinant vaccinia virus: their role in the suppression of BLV replication. Microbiol. Immunol. 36: 1317-1323.
33. Onuma, M., Hodatsu, T., Yamamoto, S., Higashihara, M., Masu, S., Mikami, T., and Izawa, H. 1984. Protection by vaccination against bovine leukemia virus infection in sheep. Am. J. Vet. Res. 45: 1212-1215.
34. + T cells in response to gag- and env-encoded BLV proteins. J. Virol. 70: 7584-7593.
35. Outteridge, P.M., Andersson, L., Douch, P.G., Green, R.S., Gwakisa, P.S., Hohenhaus, M.A., and Mikko, S. 1996. The PCR typing of MHC-DRB genes in the sheep using primers for an intronic microsatellite: application to nematode parasite resistance. Immunol. Cell Biol. 74: 330-336.
36. Portetelle, D., Limbach, K., Burny, A., Mammerickx, M., Desmettre, P., Riviere, M., Zavada, J., and Paoletti, E. 1991. Recombinant vaccinia virus expression of the bovine leukaemia virus envelope gene and protection of immunized sheep against infection. Vaccine 9: 194-200.
37. Pyeon, D., O'Reilly, K.L., and Splitter, G.A. 1996. Increased interleukin-10 mRNA expression in tumor-bearing or persistently lymphocytotic animals infected with bovine leukemia virus. J. Virol. 70: 5706-5710.
38. Pyeon, D., and Splitter, G.A. 1998. Interleukin-12 p40 mRNA expression in bovine leukemia virus-infected animals: increase in alymphocytosis but decrease in persistent lymphocytosis. J. Virol. 72: 6917-6921.
39. Radke, K., Grossman, D., and Kidd, L.C. 1990. Humoral immune response of experimentally infected sheep defines two early periods of bovine leukemia virus replication. Microb. Pathog. 9: 159-171.
40. Schwaiger, F.W., Gostomski, D., Stear, M.J., Duncan, J.L., McKellar, Q.A., Epplen, J.T., and Buitkamp, J. 1995. An ovine major histocompatibility complex DRB1 allele is associated with low faecal egg counts following natural, predominantly Ostertagia circumcincta infection. Int. J. Parasitol. 25: 815-822.
41. Shwartz, I., and Levy, D. 1994. Pathobiology of bovine leukemia virus. Vet. Res. (Paris) 25: 521-536.
42. Stem, L.J., Brown, J.H., Jardetzky, T.S., Gorga, J.C., Urban, R.G., Strominger, J.L., and Wiley, D.C. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368: 215-221.
43. Tajilna, S., Ikawa, Y., and Aida, Y. 1998. Complete bovine leukemia virus (BLV) provirus is conserved in BLV-infected cattle throughout the course of B-cell lymphosarcoma development. J. Virol. 72: 7569-7576.
44. Takeshima, S., Ikegami, M., Morita, M., Nakai, Y., and Aida, Y. 2001. Identification of new bovine BoLA-DRB3 alleles by sequence-based typing. Immunogenetics 53: 74-81.
45. Takeshima, S., Nakai, Y., Ohta, M., and Aida, Y. 2002. Short communication: characterization of DRB3 alleles in the MHC of Japanese Shorthorn Cattle by polymerase chain reaction-sequence-based typing. J. Dairy Sci. 85: 1630-1632.
46. Trueblood, E.S., Brown, W.C., Palmer, G.H., Davis, W.C., Stone, D.M., and McElwain, T.F. 1998. B-lymphocyte proliferation during bovine leukemia virus-induced persistent lymphocytosis is enhanced by T-lymphocyte-derived interleukin-2. J. Virol. 72: 3169-3177.
47. Yakobson, B., Brenner, J., Ungar-Waron, H., and Trainin, Z. 1998. Short-termed expression of interleukin-12 during experimental BLV infection may direct disease progression to persistent lymphocytosis. Vet. Immunol. Immunopathol. 64:207-218.
48. Xu, A., van Eijk, M.J., Park, C., and Lewin, H.A. 1993. Polymorphism in BoLA-DRB3 exon 2 correlates with resistance to persistent lymphocytosis caused by bovine leukemia virus. J. Immunol. 151: 6977-6985.